Fundz

Immucell Corp /De/ reported raising $3.46 Million in an initial SEC Form D filing

PUBLIC · ICCCOct 24, 2016

Amount Raised

$3.46 Million

$3.46 Million sold, per SEC Form D (first sale Oct 24, 2016)

Round Type

Seed

PortlandManufacturingBiotechnologyHealthcareAgriculture and FarmingHealth CareAnimal Feed

Who else raised in Healthcare and Agriculture and Farming around the same time

Companies in the same sectors as ImmuCell that raised within 45 days of this round, from Fundz verified event records.

  • Precision Optics Corporation raised $800K (Seed) on December 6, 2016.
  • Monteris Medical raised $6.8M on November 21, 2016.
  • T2 Biosystems raised $40M on September 27, 2016.
  • Citius Pharmaceuticals, Inc. raised $390K (Seed) on December 8, 2016.
  • Kandu Health™ raised $2.6M (Seed) on December 1, 2016.
  • Eagle Pharmaceuticals raised $2.7M (Seed) on November 23, 2016.

Who to call at ImmuCell, and when

A new round usually means ImmuCell is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ImmuCell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ImmuCell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ImmuCell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ImmuCell

Location

Portland, Maine, United States

About

ImmuCell Corporation is a growing animal health company that develops, manufactures, and markets scientifically proven and practical products aimed at improving the health and productivity of dairy and beef cattle. The company is known for its product First Defense®, which provides immediate immunity to newborn calves, and is developing Re-Tain®, a treatment for subclinical mastitis in dairy cows. ImmuCell is dedicated to advancing animal health without the use of traditional antibiotics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ImmuCell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at ImmuCell. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ImmuCell's next move

See what Strategic adds

ImmuCell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.